RE:Keystone FinancialHere's the revised ad. GLTA
As we celebrate labour day this weekend, we look back at the unknown, high-quality earnings Small-Cap stock recommended one year ago to this date.
That company, Cipher Pharmaceuticals (CPH:TSX) is now the best performing stock on the entire Toronto Stock Exchange over the past year, up 388.17%.
Do not miss out on our last 10x Stock Webinar this coming week – where we profile 5-6 new small-cap stock buy recommendations.
September 5th @ 4:00 PM Pacific / 7:00 PM Eastern. The event is 86% sold out.
If you attended KeyStone’s Fall 2023 Live Webinars and became a client to our Small-Cap Research, below we provide Quick Updates on the first two Canadian Small-Cap Recommendations new clients received following the event.
Quick Update:
Cipher Pharmaceuticals (CPH:TSX)
Recommended: August 28, 2023, at $3.89
Today’s Price: $18.99
Gain: 388.17%
Cipher (CPH:TSX) is a unique specialty pharmaceutical Small-Cap Stock that is profitable, growing organically & via acquisitions, with a strong cash rich (originally 45%+ of its value in cash & no debt) balance sheet. The stock recently made a transformational acquisition and continues to report solid financial results driving it to new highs. Cipher is a recent excellent example of how research can produce strong gains for clients.
Cipher has now gained over 388% in less than one year. The huge gains are not driven by hype but powered by strong earnings and a transformational acquisition made primarily from cash on hand without diluting existing shareholders.
Quick Update:
VitalHub (VHI:TSX)
Recommended: November 2023, at $3.24
Today’s Price: $8.02
Gain: 147.53%
KeyStone’s second Small-Cap BUY recommendation to clients following our 2023 Webinars, was VitalHub (VHI:TSX), a small-cap Canadian healthcare software company, at a price of $3.24. We had followed VitalHub and interviewed management for years, but were monitoring the stock for an attractive entry point. Just 9 months after our initial recommendation the stock rose 147.53% to $8.02, driven by strong cash flow generation, a significant acquisition and a cash rich balance sheet.
Do not miss out on the next Cipher or VitalHub.